This Article Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Christensen, S. Articles by Wagner, J. Search for Related Content PubMed PubMed Citation Articles by Christensen, S. Articles by Wagner, J. Related Collections Managed Care - Medicare Medicare Pharmaceuticals

Health Affairs, Vol 19, Issue 2, 212-218
Copyright © 2000 by Project HOPE

DataWatch

The costs of a Medicare prescription drug benefit

This paper describes a preliminary cost estimate, prepared by the Congressional Budget Office (CBO), of President Clinton's 1999 prescription drug benefit proposal. The CBO estimated that the new benefit would increase net Medicare outlays by $136 billion between 2002 and 2009, although these estimates are highly uncertain. Because the proposal included an annual cap on the amount of the benefit, it did not require consideration of an important effect of a more comprehensive benefit: higher prices for some drugs. Estimates of future proposals for a Medicare prescription drug benefit may require consideration of that pricing effect.

                      What's this?

This article has been cited by other articles:

				J. Mitchell, H. F. Mathews, L. M. Hunt, K. H. Cobb, and R. W. Watson Mismanaging Prescription Medications Among Rural Elders: The Effects of Socioeconomic Status, Health Status, and Medication Profile Indicators Gerontologist, June 1, 2001; 41(3): 348 - 356. [Abstract] [Full Text] [PDF]